{
    "organizations": [],
    "uuid": "d612d258424839ee731dcbb1fcc79ce4ba993742",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-emerald-health-therapeutics-announ/brief-emerald-health-therapeutics-announces-18-mln-prospectus-sale-idUSFWN1PY11Y",
    "ord_in_thread": 0,
    "title": "BRIEF-Emerald Health Therapeutics Announces $18 Mln Prospectus Sale",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Emerald Health Therapeutics Inc:\n* EMERALD HEALTH THERAPEUTICS ANNOUNCES $18 MILLION PROSPECTUS SALE; CONCURRENT SECONDARY SALE\n* EMERALD HEALTH THERAPEUTICS INC - ENTERED INTO A BINDING TERM SHEET WITH A SINGLE CANADIAN INSTITUTIONAL ACCREDITED INVESTOR\n* EMERALD HEALTH THERAPEUTICS INC - INVESTOR AGREED TO PURCHASE 3 MILLION UNITS OF COMPANY AT A PRICE OF $6.00 PER UNIT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T21:21:00.000+02:00",
    "crawled": "2018-02-09T17:00:21.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "emerald",
        "health",
        "therapeutic",
        "inc",
        "emerald",
        "health",
        "therapeutic",
        "announces",
        "million",
        "prospectus",
        "sale",
        "concurrent",
        "secondary",
        "sale",
        "emerald",
        "health",
        "therapeutic",
        "inc",
        "entered",
        "binding",
        "term",
        "sheet",
        "single",
        "canadian",
        "institutional",
        "accredited",
        "investor",
        "emerald",
        "health",
        "therapeutic",
        "inc",
        "investor",
        "agreed",
        "purchase",
        "million",
        "unit",
        "company",
        "price",
        "per",
        "unit",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}